---
title: "Liuguo Chemical: Net loss of 66.7255 million yuan in the first quarter of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238015311.md"
description: "Liuguo Chemical announced that in the first quarter of 2025, operating revenue was 1.604 billion yuan, a year-on-year increase of 37.41%. The net loss was 66.7255 million yuan, compared to a net profit of 4.6461 million yuan in the same period last year"
datetime: "2025-04-29T09:09:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238015311.md)
  - [en](https://longbridge.com/en/news/238015311.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238015311.md)
generator: "portal-rs"
---

# Liuguo Chemical: Net loss of 66.7255 million yuan in the first quarter of 2025

Liuguo Chemical announced that its operating revenue in the first quarter of 2025 was 1.604 billion yuan, a year-on-year increase of 37.41%. The net loss was 66.7255 million yuan, compared to a net profit of 4.6461 million yuan in the same period last year

### Related Stocks

- [600470.CN](https://longbridge.com/en/quote/600470.CN.md)

## Related News & Research

- [Jiangsu Lopal Tech Shareholders Approve Capital Increase and Registry Changes at EGM](https://longbridge.com/en/news/297933378.md)
- [Hugging Face's new duck robot is selling fast. A Chinese chip powers it](https://longbridge.com/en/news/297613369.md)
- [Asia Fuel Oil-VLSFO cash premium steadies, HSFO extends decline](https://longbridge.com/en/news/297900702.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [Biocytogen licenses fully human VHH antibody to Qilu Pharma in non-exclusive deal](https://longbridge.com/en/news/297781804.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**